These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30683242)

  • 1. Effect of pneumococcal conjugate vaccine introduction on childhood pneumonia mortality in Brazil: a retrospective observational study.
    Schuck-Paim C; Taylor RJ; Alonso WJ; Weinberger DM; Simonsen L
    Lancet Glob Health; 2019 Feb; 7(2):e249-e256. PubMed ID: 30683242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumonia hospital admissions in Fiji: a time-series analysis.
    Reyburn R; Tuivaga E; Nguyen CD; Ratu FT; Nand D; Kado J; Tikoduadua L; Jenkins K; de Campo M; Kama M; Devi R; Rafai E; Weinberger DM; Mulholland EK; Russell FM
    Lancet Glob Health; 2021 Jan; 9(1):e91-e98. PubMed ID: 33227258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct and indirect impact of 10-valent pneumococcal conjugate vaccine introduction on pneumonia hospitalizations and economic burden in all age-groups in Brazil: A time-series analysis.
    Andrade AL; Afonso ET; Minamisava R; Bierrenbach AL; Cristo EB; Morais-Neto OL; Policena GM; Domingues CMAS; Toscano CM
    PLoS One; 2017; 12(9):e0184204. PubMed ID: 28880953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early impact of 10-valent pneumococcal conjugate vaccine in childhood pneumonia hospitalizations using primary data from an active population-based surveillance.
    Sgambatti S; Minamisava R; Bierrenbach AL; Toscano CM; Vieira MA; Policena G; Andrade AL
    Vaccine; 2016 Jan; 34(5):663-670. PubMed ID: 26706272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically-confirmed pneumonia and clinically-defined pneumonia in Kenyan children: an interrupted time-series analysis.
    Silaba M; Ooko M; Bottomley C; Sande J; Benamore R; Park K; Ignas J; Maitland K; Mturi N; Makumi A; Otiende M; Kagwanja S; Safari S; Ochola V; Bwanaali T; Bauni E; Gleeson F; Deloria Knoll M; Adetifa I; Marsh K; Williams TN; Kamau T; Sharif S; Levine OS; Hammitt LL; Scott JAG
    Lancet Glob Health; 2019 Mar; 7(3):e337-e346. PubMed ID: 30784634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine (PCV-10) in Children in Chile: A Nested Case-Control Study Using Nationwide Pneumonia Morbidity and Mortality Surveillance Data.
    Diaz J; Terrazas S; Bierrenbach AL; Toscano CM; Alencar GP; Alvarez A; Valenzuela MT; Andrus J; del Aguila R; Hormazábal JC; Araya P; Pidal P; Matus CR; de Oliveira LH
    PLoS One; 2016; 11(4):e0153141. PubMed ID: 27058873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children.
    Nair H; Watts AT; Williams LJ; Omer SB; Simpson CR; Willocks LJ; Cameron JC; Campbell H
    BMC Infect Dis; 2016 Aug; 16():390. PubMed ID: 27506837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of pneumococcal conjugate vaccine against hospital admissions for pneumonia in Australian children: a retrospective, population-based, record-linked cohort study.
    Fathima P; Gidding HF; McIntyre PB; Snelling TL; McCallum L; de Klerk N; Blyth CC; Liu B; Moore HC
    Lancet Child Adolesc Health; 2019 Oct; 3(10):713-724. PubMed ID: 31439496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The worldwide impact of the seven-valent pneumococcal conjugate vaccine.
    Fitzwater SP; Chandran A; Santosham M; Johnson HL
    Pediatr Infect Dis J; 2012 May; 31(5):501-8. PubMed ID: 22327872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Declines in Pneumonia Mortality Following the Introduction of Pneumococcal Conjugate Vaccines in Latin American and Caribbean Countries.
    de Oliveira LH; Shioda K; Valenzuela MT; Janusz CB; Rearte A; Sbarra AN; Warren JL; Toscano CM; Weinberger DM;
    Clin Infect Dis; 2021 Jul; 73(2):306-313. PubMed ID: 32448889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review on the impact of the pneumococcal conjugate vaccine ten valent (PCV10) or thirteen valent (PCV13) on all-cause, radiologically confirmed and severe pneumonia hospitalisation rates and pneumonia mortality in children 0-9 years old.
    Reyburn R; Tsatsaronis A; von Mollendorf C; Mulholland K; Russell FM;
    J Glob Health; 2023 Feb; 13():05002. PubMed ID: 36734192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on childhood pneumonia hospitalizations in Brazil two years after introduction.
    Scotta MC; Veras TN; Klein PC; Tronco V; Polack FP; Mattiello R; Pitrez PMC; Jones MH; Stein RT; Pinto LA
    Vaccine; 2014 Jul; 32(35):4495-4499. PubMed ID: 24958703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Pneumococcal Conjugate Vaccines on Pneumonia Hospitalizations in High- and Low-Income Subpopulations in Brazil.
    Warren JL; Shioda K; Kürüm E; Schuck-Paim C; Lustig R; Taylor RJ; Simonsen L; Weinberger DM
    Clin Infect Dis; 2017 Nov; 65(11):1813-1818. PubMed ID: 29020195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial.
    Lucero MG; Nohynek H; Williams G; Tallo V; Simões EA; Lupisan S; Sanvictores D; Forsyth S; Puumalainen T; Ugpo J; Lechago M; de Campo M; Abucejo-Ladesma E; Sombrero L; Nissinen A; Soininen A; Ruutu P; Riley I; Mäkelä HP
    Pediatr Infect Dis J; 2009 Jun; 28(6):455-62. PubMed ID: 19483514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated impact of the pneumococcal conjugate vaccine on pneumonia mortality in South Africa, 1999 through 2016: An ecological modelling study.
    Kleynhans J; Tempia S; Shioda K; von Gottberg A; Weinberger DM; Cohen C
    PLoS Med; 2021 Feb; 18(2):e1003537. PubMed ID: 33591995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of pneumococcal conjugate vaccine on pneumonia hospitalization and mortality in children and elderly in Ecuador: Time series analyses.
    Jimbo Sotomayor R; Toscano CM; Sánchez Choez X; Vilema Ortíz M; Rivas Condo J; Ghisays G; Haneuse S; Weinberger DM; McGee G; de Oliveira LH
    Vaccine; 2020 Oct; 38(45):7033-7039. PubMed ID: 32981782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control.
    Thorrington D; Andrews N; Stowe J; Miller E; van Hoek AJ
    BMC Med; 2018 Feb; 16(1):13. PubMed ID: 29415741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: Time series analyses.
    Suarez V; Michel F; Toscano CM; Bierrenbach AL; Gonzales M; Alencar AP; Ruiz Matus C; Andrus JK; de Oliveira LH
    Vaccine; 2016 Sep; 34(39):4738-4743. PubMed ID: 27521230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study.
    Palmu AA; Rinta-Kokko H; Nohynek H; Nuorti JP; Kilpi TM; Jokinen J
    PLoS One; 2017; 12(3):e0172690. PubMed ID: 28249015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in childhood pneumonia and infant mortality rates following introduction of the 13-valent pneumococcal conjugate vaccine in Nicaragua.
    Becker-Dreps S; Amaya E; Liu L; Moreno G; Rocha J; Briceño R; Alemán J; Hudgens MG; Woods CW; Weber DJ
    Pediatr Infect Dis J; 2014 Jun; 33(6):637-42. PubMed ID: 24445827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.